Schäfer H - Search Results

1

CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells.

Trauzold A, Wermann H, Arlt A, Schütze S, Schäfer H, Oestern S, Röder C, Ungefroren H, Lampe E, Heinrich M, Walczak H, Kalthoff H. Trauzold A, et al. Among authors: schafer h. Oncogene. 2001 Jul 12;20(31):4258-69. doi: 10.1038/sj.onc.1204559. Oncogene. 2001. PMID: 11464292

2

PRG1: a novel early-response gene transcriptionally induced by pituitary adenylate cyclase activating polypeptide in a pancreatic carcinoma cell line.

Schäfer H, Trauzold A, Siegel EG, Fölsch UR, Schmidt WE. Schäfer H, et al. Cancer Res. 1996 Jun 1;56(11):2641-8. Cancer Res. 1996. PMID: 8653710

3

Identification of novel growth-related genes linked to the mitogenic effect of PACAP on the rat pancreatic acinar cell line, AR4-2J.

Schäfer H, Trauzold A, Fölsch UR, Schmidt WE. Schäfer H, et al. Ann N Y Acad Sci. 1996 Dec 26;805:760-7. doi: 10.1111/j.1749-6632.1996.tb17554.x. Ann N Y Acad Sci. 1996. PMID: 8993474

4

The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene.

Schäfer H, Trauzold A, Sebens T, Deppert W, Fölsch UR, Schmidt WE. Schäfer H, et al. Oncogene. 1998 May 14;16(19):2479-87. doi: 10.1038/sj.onc.1201788. Oncogene. 1998. PMID: 9627114

5

The promoter of human p22/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NFkappaB.

Schäfer H, Diebel J, Arlt A, Trauzold A, Schmidt WE. Schäfer H, et al. FEBS Lett. 1998 Oct 2;436(2):139-43. doi: 10.1016/s0014-5793(98)01109-0. FEBS Lett. 1998. PMID: 9781666 Free article.

6

p22/PACAP response gene 1 (PRG1): a putative target gene for the tumor suppressor p53.

Schäfer H, Trauzold A, Sebens T, Deppert W, Fölsch UR, Schmidt WE. Schäfer H, et al. Ann N Y Acad Sci. 1998 Dec 11;865:27-36. doi: 10.1111/j.1749-6632.1998.tb11159.x. Ann N Y Acad Sci. 1998. PMID: 9927993

7

Human PACAP response gene 1 (p22/PRG1): proliferation-associated expression in pancreatic carcinoma cells.

Schäfer H, Lettau P, Trauzold A, Banasch M, Schmidt WE. Schäfer H, et al. Pancreas. 1999 May;18(4):378-84. doi: 10.1097/00006676-199905000-00008. Pancreas. 1999. PMID: 10231843

8

p22/PRG1: a novel early response gene in pancreatic cancer cells regulated by p53 and NF kappa B.

Schmidt WE, Arlt A, Trauzold A, Schäfer H. Schmidt WE, et al. Among authors: schafer h. Ann N Y Acad Sci. 1999 Jun 30;880:147-56. doi: 10.1111/j.1749-6632.1999.tb09517.x. Ann N Y Acad Sci. 1999. PMID: 10415858 No abstract available.

9

The putative apoptosis inhibitor IEX-1L is a mutant nonspliced variant of p22(PRG1/IEX-1) and is not expressed in vivo.

Schäfer H, Arlt A, Trauzold A, Hünermann-Jansen A, Schmidt WE. Schäfer H, et al. Biochem Biophys Res Commun. 1999 Aug 19;262(1):139-45. doi: 10.1006/bbrc.1999.1131. Biochem Biophys Res Commun. 1999. PMID: 10448082

10

Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells.

Arlt A, Grobe O, Sieke A, Kruse ML, Fölsch UR, Schmidt WE, Schäfer H. Arlt A, et al. Among authors: schafer h. Oncogene. 2001 Jan 4;20(1):69-76. doi: 10.1038/sj.onc.1204061. Oncogene. 2001. PMID: 11244505

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,180 results

Search Page

Filters